Shield Therapeutics plc

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

61

Website

www.shieldtherapeutics.com

Country

🇬🇧 United Kingdom

Exchange

LSE

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.

Key Stats

52-Week Range

£0.00£12.50

Beta1.76

Trailing P/EN/A

Forward P/E7.73

Trailing EPS-0.01

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean Price£16.67

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.